Startup Spotlight at BIO-Europe
This exciting competition offers entrepreneurs an affordable opportunity to engage with top-tier investors and other important players in the biotech industry to take their business to the next level. Who will follow in the footsteps of previous winners like STAb Therapeutics? Join us to find out as we blend Vienna's historic coffee culture with tomorrow's biotech breakthroughs!
The next Startup Spotlight will take place at BIO-Europe Spring in Lisbon, Portugal. Applications are now open, you can learn more here.

Meet the 2025 Startup Spotlight winner
Congratulations to the winner of the Startup Spotlight at BIO-Europe 2025, Fusix Biotech GmbH!
Learn what made Fusix stand out at this year's competition from CEO, Jennifer Altomonte.
Meet the 2025 Startup Spotlight Finalists
Much like Vienna's renowned coffee houses where ideas have been brewing for centuries, BIO-Europe 2025 creates the perfect atmosphere for innovation to percolate. In a city where Kaffeehauskultur has inspired great minds from Mozart to Freud, our finalists will have their moment to shine while we all enjoy Vienna's legendary hospitality and rich tradition of collaborative thinking over the perfect cup.
Fusix Biotech
Year founded: 2022
State of ownership: Private
Area of focus: Oncology
Lead product status: Preclinical
Immunokey
Year founded: 2023
State of ownership: Public
Area of focus: Cell and Gene Therapies
Lead product status: Discovery
Nanogrow Biotech
https://nanogrowbiotech.com
Year founded: 2022
State of ownership: Private
Area of focus: Oncology
Lead product status: Pre-clinical
MyoPax
Year founded: 2022
State of ownership: Private
Area of focus: Cell and Gene Therapies
Lead product status: Preclinical
OncoLab Co., Ltd.
Year founded: 2024
State of ownership: Private
Area of focus: Oncology
Lead product status: Preclinical
Oragen Therapeutics
Year founded: 2025
State of ownership: Private
Area of focus: Immunology
Lead product status: Preclinical
P3 Therapeutics
Year founded: 2024
State of ownership: Private
Area of focus: Immunology
Lead product status: Discovery
ReEngage Therapeutics
Year founded: 2023
State of ownership: Private
Area of focus: Oncology
Lead product status: Phase I
2025 Startup Spotlight Supporter
2025 Startup Spotlight Judges

How has the Startup Spotlight impacted previous winners?
Hear from former Startup Spotlight winner Yemi Onakunle, Founder & CEO of Mabswitch, as he talks about what he is up to now since taking home the gold.











